These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes. Bator JM, Cohen RL, Chambers DA. Exp Cell Res; 1998 Jul 10; 242(1):110-9. PubMed ID: 9665808 [Abstract] [Full Text] [Related]
7. Role of plasminogen activator inhibitor-2 (PAI-2) in keratinocyte differentiation. Jang S, Yang TH, An EJ, Yoon HK, Sohn KC, Cho AY, Ryu EK, Park YS, Yoon TY, Lee JH, Kim CD. J Dermatol Sci; 2010 Jul 10; 59(1):25-30. PubMed ID: 20494554 [Abstract] [Full Text] [Related]
8. The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT). Reinartz J, Link J, Todd RF, Kramer MD. Exp Cell Res; 1994 Oct 10; 214(2):486-98. PubMed ID: 7925643 [Abstract] [Full Text] [Related]
9. Plasminogen activator inhibitor type 2: an intracellular keratinocyte differentiation product that is incorporated into the cornified envelope. Jensen PJ, Wu Q, Janowitz P, Ando Y, Schechter NM. Exp Cell Res; 1995 Mar 10; 217(1):65-71. PubMed ID: 7867722 [Abstract] [Full Text] [Related]
10. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts. Allan EH, Martin TJ. J Cell Physiol; 1995 Dec 10; 165(3):521-9. PubMed ID: 7593231 [Abstract] [Full Text] [Related]
11. Plasminogen activator inhibitor type 2 (PAI-2) is present in normal human conjunctiva. Massaro-Giordano M, Marshall CM, Lavker RM, Jensen PJ, Risse Marsh BC. J Cell Physiol; 2005 Nov 10; 205(2):295-301. PubMed ID: 15887231 [Abstract] [Full Text] [Related]
13. The urokinase plasminogen activator (uPA) system in uterine natural killer cells in the placental bed during early pregnancy. Naruse K, Lash GE, Bulmer JN, Innes BA, Otun HA, Searle RF, Robson SC. Placenta; 2009 May 10; 30(5):398-404. PubMed ID: 19272641 [Abstract] [Full Text] [Related]
14. Reciprocal upregulation of urokinase plasminogen activator and its inhibitor, PAI-2, by Borrelia burgdorferi affects bacterial penetration and host-inflammatory response. Haile WB, Coleman JL, Benach JL. Cell Microbiol; 2006 Aug 10; 8(8):1349-60. PubMed ID: 16882037 [Abstract] [Full Text] [Related]
15. A structural basis for differential cell signalling by PAI-1 and PAI-2 in breast cancer cells. Croucher DR, Saunders DN, Stillfried GE, Ranson M. Biochem J; 2007 Dec 01; 408(2):203-10. PubMed ID: 17696882 [Abstract] [Full Text] [Related]
17. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression. Lockwood CJ, Krikun G, Papp C, Aigner S, Schatz F. J Clin Endocrinol Metab; 1995 Apr 01; 80(4):1100-5. PubMed ID: 7714076 [Abstract] [Full Text] [Related]
18. [Expression and significance of the urokinase-type plasminogen activator and its inhibitors in squamous cell carcinoma of human larynx]. Zhao EM, Han DM, Yu ZK, Fan EZ, Li Y. Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb 01; 38(1):39-42. PubMed ID: 12778766 [Abstract] [Full Text] [Related]
19. Plasminogen activator inhibitor type-2 in the lesional epidermis of lupus erythematosus. Bechtel MJ, Schaefer BM, Kramer MD. Br J Dermatol; 1996 Mar 01; 134(3):411-9. PubMed ID: 8731662 [Abstract] [Full Text] [Related]
20. Dispase-mediated basal detachment of cultured keratinocytes induces urokinase-type plasminogen activator (uPA) and its receptor (uPA-R, CD87). Schaefer BM, Reinartz J, Bechtel MJ, Inndorf S, Lang E, Kramer MD. Exp Cell Res; 1996 Nov 01; 228(2):246-53. PubMed ID: 8912717 [Abstract] [Full Text] [Related] Page: [Next] [New Search]